Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4632]

New test follows the molecular footsteps that lead to oesophageal cancer

New test follows the molecular footsteps that lead to oesophageal cancer

Advanced breast cancer: benefits of trastuzumab outweigh the risk of harm

Advanced breast cancer: benefits of trastuzumab outweigh the risk of harm

Immune cells found near tumours boost breast cancer survival

Immune cells found near tumours boost breast cancer survival

Advances in personalised medicine

Advances in personalised medicine

ASCO 2014: HPV-targeted adoptive T cell therapy may provide a new strategy for advanced cervical cancer

ASCO 2014: HPV-targeted adoptive T cell therapy may provide a new strategy for advanced cervical cancer

ASCO 2014: Adjuvant exemestane is more effective than tamoxifen when combined with ovarian function suppression in young women with hormone-sensitive, early-stage breast cancer

ASCO 2014: Adjuvant exemestane is more effective than tamoxifen when combined with ovarian function suppression in...

ASCO 2014: Adding lapatinib to adjuvant trastuzumab does not improve outcomes in early- stage HER2-positive breast cancer

ASCO 2014: Adding lapatinib to adjuvant trastuzumab does not improve outcomes in early- stage HER2-positive breast...

ASCO 2014: Second-line treatment with ramucirumab plus docetaxel extends survival in advanced NSCLC

ASCO 2014: Second-line treatment with ramucirumab plus docetaxel extends survival in advanced NSCLC

Guideline update recommends tamoxifen for up to 10 years for women with non-metastatic hormone receptor positive breast cancer

Guideline update recommends tamoxifen for up to 10 years for women with non-metastatic hormone receptor positive...

New blood-based biomarker panel may enable pancreatic cancer diagnosis at an early stage

New blood-based biomarker panel may enable pancreatic cancer diagnosis at an early stage

More from ecancer